In a welcome move, Appian Cl A saw its Relative Strength Rating improve from 69 to 73 on Wednesday.
IBD's proprietary rating identifies market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price movement over the last 52 weeks holds up against all the other stocks in our database.
Decades of market research reveals that the best stocks typically have an RS Rating north of 80 in the early stages of their moves. See if Appian Cl A can continue to show renewed price strength and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
While Appian Cl A is not near an ideal buy point right now, see if it is able to form and break out of a proper chart pattern.
The company reported 0% EPS growth last quarter. Sales rose 12%.
The company holds the No. 6 rank among its peers in the Computer Software-Design industry group. Cadence Design Systems, Autodesk and Altair Engineering Cl A are among the top 5 highly rated stocks within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
